Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lineage Cell Therapeutics (LCTX) Income from Non-Controlling Interests: 2010-2025

Historic Income from Non-Controlling Interests for Lineage Cell Therapeutics (LCTX) over the last 15 years, with Sep 2025 value amounting to $29,000.

  • Lineage Cell Therapeutics' Income from Non-Controlling Interests fell 12.12% to $29,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $148,000, marking a year-over-year increase of 127.69%. This contributed to the annual value of $27,000 for FY2024, which is 285.71% up from last year.
  • As of Q3 2025, Lineage Cell Therapeutics' Income from Non-Controlling Interests stood at $29,000, which was down 71.00% from $100,000 recorded in Q2 2025.
  • Lineage Cell Therapeutics' Income from Non-Controlling Interests' 5-year high stood at $100,000 during Q2 2025, with a 5-year trough of -$200,000 in Q4 2021.
  • In the last 3 years, Lineage Cell Therapeutics' Income from Non-Controlling Interests had a median value of $23,000 in 2024 and averaged $14,455.
  • Per our database at Business Quant, Lineage Cell Therapeutics' Income from Non-Controlling Interests tumbled by 1,638.46% in 2021 and then skyrocketed by 869.23% in 2025.
  • Lineage Cell Therapeutics' Income from Non-Controlling Interests (Quarterly) stood at -$200,000 in 2021, then soared by 96.00% to -$8,000 in 2022, then spiked by 862.50% to $61,000 in 2023, then tumbled by 62.30% to $23,000 in 2024, then decreased by 12.12% to $29,000 in 2025.
  • Its Income from Non-Controlling Interests was $29,000 in Q3 2025, compared to $100,000 in Q2 2025 and -$4,000 in Q1 2025.